美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Tetraphase Pharmaceuticals Inc.

2.20

0.0000

成交量：- -

成交额：- -

市值：1,597.91万

市盈率：-0.17

高：2.20

开：2.20

低：2.20

收：2.20

52周最高：8.60

52周最低：0.5600

股本：726.32万

流通股本：503.36万

量比：- -

换手率：- -

股息：- -

股息率：- -

每股收益(TTM):-13.3067

每股收益(LYR):-22.8513

净资产收益率：-138.80%

总资产收益率：-51.46%

市净率：0.58

市盈率(LYR):-0.10

数据加载中...

总览公司新闻资讯公告

公司资料

公司名字：

Tetraphase Pharmaceuticals Inc.

交易所：

NASDAQ

成立时间：

- -

员工人数：

- -

公司地址：

- -

官网：

http://www.tphase.com

邮编：

- -

电话：

- -

传真：

- -

简介：

Tetraphase Pharmaceuticals, Inc.依据特拉华州法律于2006年7月7日成立，是一家临床阶段的生物制药公司，利用其专有的化学技术为严重的、威胁生命的、有多种抗药性的感染病的治疗创造新型的抗生素。公司领先的药品替代物eravacycline是一种完全的合成四环素衍生物，将作为首要的偏方单一治疗法发展成一种广泛的静脉注射和口服的抗生素，用于治疗抗多种药物感染病的治疗，包括革兰氏阴性感染病。公司最近为患有复杂腹内感染病（cIAI）患者采用静脉内给药的方式成功完成了eravacycline阶段二的临床试验，目前正在进行关键性的eravacycline阶段三测试。公司期望完成两项全球性的eravacycline阶段三临床试验，一项是对cIAI的治疗试验，另一项是对复杂尿路感染饼（cUTI）的治疗试验。

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠： 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠： 港股&Crypto 0佣0平台费、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/TTPH/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TTPH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TTPH\",,,,,undefined,":{"symbol":"TTPH","market":"US","secType":"STK","nameCN":"Tetraphase Pharmaceuticals Inc.","latestPrice":2.2,"timestamp":1595966400000,"preClose":2.2,"halted":4,"volume":0,"delay":0,"changeRate":0,"floatShares":5033625,"shares":7263236,"eps":-13.306672,"marketStatus":"退市","change":0,"latestTime":"03-02 10:55:12 EST","open":2.2,"high":2.2,"low":2.2,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-13.306672,"tradingStatus":0,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1772485200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1363752000000,"exchange":"NASDAQ","adjPreClose":2.2,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TTPH\",,,,,undefined,":{"symbol":"TTPH","floatShares":5033625,"roa":"-51.46%","roe":"-138.80%","lyrEps":-22.85132,"shares":7263236,"dividePrice":0,"high":2.2,"amplitude":0,"preClose":2.2,"low":2.2,"week52Low":0.56,"pbRate":"0.58","week52High":8.6,"institutionHeld":0,"latestPrice":2.2,"eps":-13.306672,"divideRate":0,"volume":0,"delay":0,"ttmEps":-13.306672,"open":2.2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TTPH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2020-05-07","symbol":"TTPH","fiscalQuarterEnding":"2020/03","expectedEps":-1.63,"name":null,"time":"","type":"earning","dateTimestamp":1588824000000,"reportTimeType":"","actualEps":-1.31},{"market":"US","date":"2020-03-12","symbol":"TTPH","fiscalQuarterEnding":"2019/12","expectedEps":-5.68,"name":null,"time":"","type":"earning","dateTimestamp":1583985600000,"reportTimeType":"","actualEps":null},{"date":"2019-11-12","symbol":"TTPH","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2019/09","expectedEps":-6.27,"defaultRemindTime":1573592400000,"name":null,"time":"盘后","dateTimestamp":1573534800000,"actualEps":null},{"market":"US","date":"2019-09-27","symbol":"TTPH","type":"split","dateTimestamp":1569556800000,"forFactor":20,"toFactor":1,"ratio":20},{"date":"2019-08-08","symbol":"TTPH","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2019/06","expectedEps":-0.38,"defaultRemindTime":1565294400000,"name":null,"time":"盘后","dateTimestamp":1565236800000,"actualEps":-0.18}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TTPH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TTPH\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TTPH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TTPH","date":"2020-07-28","current":-0.165331,"percent":0.148148,"low":-0.322562,"twenty":-0.24552,"median":-0.163297,"eighty":-0.111312,"high":-0.068361,"avg":-0.171046,"sd":0.066471,"marketCap":16652545},"quantilePoints":[],"updateTime":1772466912969},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.tphase.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.005},{"period":"1month","weight":-0.0136},{"period":"3month","weight":0.0038},{"period":"6month","weight":0.0635},{"period":"1year","weight":0.1725},{"period":"ytd","weight":0.006}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Tetraphase Pharmaceuticals, Inc.依据特拉华州法律于2006年7月7日成立，是一家临床阶段的生物制药公司，利用其专有的化学技术为严重的、威胁生命的、有多种抗药性的感染病的治疗创造新型的抗生素。公司领先的药品替代物eravacycline是一种完全的合成四环素衍生物，将作为首要的偏方单一治疗法发展成一种广泛的静脉注射和口服的抗生素，用于治疗抗多种药物感染病的治疗，包括革兰氏阴性感染病。公司最近为患有复杂腹内感染病（cIAI）患者采用静脉内给药的方式成功完成了eravacycline阶段二的临床试验，目前正在进行关键性的eravacycline阶段三测试。公司期望完成两项全球性的eravacycline阶段三临床试验，一项是对cIAI的治疗试验，另一项是对复杂尿路感染饼（cUTI）的治疗试验。","exchange":"NASDAQ","name":"Tetraphase Pharmaceuticals Inc.","nameEN":"Tetraphase Pharmaceuticals"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"TTPH\",market:\"US\",,,undefined,":null}}